About NuChem Therapeutics
NuChem Therapeutics is a company based in Montreal (Canada) founded in 2011. NuChem Therapeutics has completed 1 acquisition, including AmorChem. NuChem Therapeutics offers products and services including Synthetic Chemistry, Medicinal Chemistry, In Vitro Biology, Process Chemistry, and DMPK Services. NuChem Therapeutics operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nuchem Sciences Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
(Feb 22, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NuChem Therapeutics
NuChem Therapeutics offers a comprehensive portfolio of products and services, including Synthetic Chemistry, Medicinal Chemistry, In Vitro Biology, Process Chemistry, and DMPK Services.
Service for synthesizing compounds in drug research and development.
Development of compounds for therapeutic applications in drug discovery.
Testing of biological activities for advancing drug candidates.
Optimization of chemical processes for scalable production.
Analysis of drug metabolism and pharmacokinetics in research.
Funding Insights of NuChem Therapeutics
Detailed funding history for NuChem Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NuChem Therapeutics
NuChem Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AmorChem.
Investment portfolio details for NuChem Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biotech companies are funded by a venture capital firm.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for NuChem Therapeutics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - NuChem Therapeutics
Detailed financials for NuChem Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nuchem Therapeutics Comparisons
Peer comparison for NuChem Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NuChem Therapeutics
NuChem Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to pharmaceutical clients worldwide.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
Detailed competitors of NuChem Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nuchem Therapeutics
Complete news archive for NuChem Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NuChem Therapeutics
NuChem Therapeutics was founded in 2011.
NuChem Therapeutics is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
NuChem Therapeutics was established in 2011 in Montreal, Canada, as a contract research organization focused on medicinal chemistry for the biotech and pharmaceutical industries. Support is offered for preclinical candidate identification and optimization through services such as custom compound synthesis, structure-activity-relationship design, DMPK analysis, computational drug design, and assay development. Operations center on small molecule drug discovery biology.
NuChem Therapeutics's top competitors include Evotec, Crown Bioscience and NIH.
NuChem Therapeutics offers Synthetic Chemistry, Medicinal Chemistry, In Vitro Biology, Process Chemistry, and DMPK Services.
NuChem Therapeutics has made 1 acquisition, including AmorChem.